MOH Net Margin
-0.02%TTM
Period ending:
MOH FY Net Margin%
7.01%-3.60%
1999-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
MOH net margin history
Net income as a percentage of revenue. The available annual fiscal periods series contains 27 observations from Dec 31, 1999 to Dec 31, 2025.
| Period ending | Net Margin |
|---|---|
| 1.0391% | |
| 2.9004% | |
| 3.202% | |
| 2.477% | |
| 2.373% | |
| 3.465% | |
| 4.3793% | |
| 3.7427% | |
| -2.5751% | |
| 0.0452% | |
| 1.0162% | |
| 0.6437% | |
| 0.8033% | |
| 0.1624% | |
| 0.4364% | |
| 1.3453% | |
| 0.8412% | |
| 2.0048% | |
| 2.3403% | |
| 2.2807% | |
| 1.6724% | |
| 4.7456% | |
| 5.3579% | |
| 4.7358% | |
| 5.9797% | |
| 4.5424% | |
| 5.0888% |
Compare net margin
Other companies in Healthcare. Each page shows its own reporting periods and currency.
- Lilly (Eli) (LLY) net margin
- Johnson & Johnson (JNJ) net margin
- AbbVie (ABBV) net margin
- UnitedHealth Group (UNH) net margin
- Merck & Co. (MRK) net margin
- Thermo Fisher Scientific (TMO) net margin
- Amgen (AMGN) net margin
- Gilead Sciences (GILD) net margin
Compare all covered stocks by net margin →
All MOH financial metrics · MOH stock overview · How to interpret financial metrics
